Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Starting soon Not applicable

Motivational Interviewing and Subgingival Instrumentation Outcomes in Periodontitis

NCT07618533 · tracked via the Priya Life Science India tracker
Phase
Not applicable
Started
2026-06-26
Last updated
2026-06-03

Condition(s) studied

Motivational InterviewingPeriodontitisOral Hygiene

Investigational drug(s) / intervention(s)

Motivational InterviewingOral hygiene instructions

Motivational Interviewing: A single individual motivational interviewing session will be delivered to each patient at baseline and 1 month

Oral hygiene instructions: Oral hygiene instructions will be provided to each patient at baseline and at 1 month.

Study summary

Motivational Interviewing (MI) represents a patient centered counselling approach designed to facilitate behaviour change by guiding patients through the exploration and resolution of ambivalence toward positive health actions. Adapting OARS microskills (open ended questions fostering dialogue, affirmations building self-efficacy, reflective listening mirroring emotions, summarization making commitments) intertwined with the RULE framework (resisting the righting reflex, understanding personal motivations, empathic listening, empowering autonomy) helps cultivate patient's intrinsic motivation for sustained oral hygiene adherence. It effectively resolves ambivalence toward plaque control behaviours essential for periodontitis management. Grounded in MI's core spirit of equal partnership, evocation of inner values, acceptance and compassionate support, this approach fosters long term adherence to treatment. This is in contrast to oral hygiene instructions that typically employ a directive advice giving method, where clinicians provide patients with prescriptive guidance on maintaining optimal oral hygiene practices. Periodontitis staging, as defined by the 2017 World Workshop classification, delineates disease severity (Stages I-III), complexity of management, and extent of involvement, while grading (A-C) offers a prognostic indicator of the risk for future progression based on factors such as rate of advancement and responsiveness to therapy. Integrating motivational interviewing (MI) with periodontitis staging and grading creates a structured framework from diagnosis to patient centered action, enhancing adherence to stage specific treatment plans. This study seeks to investigate the influence of MI on Clinical outcomes, Patient motivation, Patient related outcomes and Patient's Self-efficacy in oral hygiene following subgingival instrumentation among patients stratified by periodontitis stage. By doing so, it aims to explore the potential of behavior change interventions to yield not only clinical improvements but also broader health benefits in the management of periodontitis.

Eligibility

Sex
ALL
Min age
30 Years
Max age
50 Years
Healthy volunteers
No
Inclusion Criteria: • Systemically healthy Patients with age group 30-50 years diagnosed with (Stage I-III) periodontitis. Exclusion Criteria: * Systemic diseases that may affect periodontal disease progression or outcome of treatment * Patients on long term antibiotics * Pregnant and lactating women * Female patients with history of menopause * Current orthodontic treatment or planning to undergo orthodontic treatment during study

Primary outcome measure(s)

  • The Dental Treatment Motivation Scale (DTMS) — Baseline, 3 month, 6 month
    The Dental Treatment Motivation Scale (DTMS)19 questionnaire will be used to measure each participant's level of motivation. . The scale has a total of 15 items, which assess intrinsic (seven questions) and extrinsic motivation (eight questions). Answers provided on a scale are from 1 to 5, where 1 = "strongly disagree" and 5 = "strongly agree." Patients will complete the questionnaire at the 3, 6 month follow-up appointment after periodontal treatment. Higher score indicates higher level of patient motivation towards dental treatment.
  • Patient related outcome Measure — Baseline, 3 month, 6 month
    The Oral Health Impact Profile-14 (OHIP-14) questionnaire will be used to measure each participant's Oral Health related quality of life (OHRQoL). It evaluates 14 questions under seven domains: functional limitation, physical pain, psychological discomfort, physical disability, psychological disability, social disability, and handicap. Each item is scored on a 5-point Likert scale (1=never to 5=very often) with total scores ranging from 0-56 (higher scores indicate worse Oral health quality of life).
  • Evaluation of Patient's Self Efficacy — Baseline, 3 month, 6 month
    The Oral Hygiene Related Self Efficacy Scale (OHSE) questionnaire will be used for assessing self-efficacy. It includes 19 items rated on 4 point Likert scale from (1) Completely confident not to (4) Completely confident. Higher scores indicate stronger belief in one's ability to maintain oral health, correlating with better hygiene practices and treatment outcomes.

Trial sites (1)

FacilityCityRegionStatus
Post Graduate Institute of Dental Sciences, Rohtak Rohtak Haryana
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07618533 on ClinicalTrials.gov ↗ ← All trials in India